Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249935 · ClinicalTrials.gov registry record · Phase 2
YCFM (Youth Correctional Facilities Males)
A Phase 2 study of Chlamydial Infection, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03249935 is a Phase 2 study of Chlamydial Infection that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03249935, a Phase 2 study of Chlamydial Infection, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is a single center (with multiple long-term YCFs) treatment trial of the CDC-recommended azithromycin regimen (1 gm PO once) for chlamydia in males. This study is designed primarily to determine the frequency of chlamydia treatment failure following azithromycin in males who do versus do not have urethral symptoms of urethral discharge and/or dysuria. Anticipated enrollment is 446 males, between the age of 12 to 21 years old, with subject participation duration of 28 days and study duration of 4 years. The primary objective of the study is to assess the microbiological efficacy of azithromycin in uncomplicated Chlamydia trachomatis infection in males with versus without urethral symptoms in YCFs.
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (1)
California
- Los Angeles County Department of Health Services - Juvenile Court Health Services - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2018-09-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03249935
The ClinicalTrials.gov registry entry for NCT03249935 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chlamydial Infection appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT03249935 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03249935 about?
NCT03249935 is a clinical study titled "YCFM (Youth Correctional Facilities Males)". The proposed study is a single center (with multiple long-term YCFs) treatment trial of the CDC-recommended azithromycin regimen (1 gm PO once) for chlamydia in males. This study is designed primarily to determine the frequency of chlamydia treatment failure following azithromycin in males who do ve...
What is the current status of trial NCT03249935?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2017-08-24. Estimated completion is 2018-09-17.
What conditions does trial NCT03249935 study?
This clinical trial studies the following conditions: Chlamydial Infection.
What interventions are being tested in trial NCT03249935?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT03249935?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03249935 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chlamydial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.